harvard medical school: "cgrp: a new era for migraine treatment." .
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid. http://lm360.us/Curfman-son-of-Samu-from-Odintsovo?Hakansonm=219 .